Stewart Colin J R, Charles Adrian, Foulkes William D
Department of Histopathology, King Edward Memorial Hospital, School for Women's and Infants' Health, University of Western Australia, Subiaco, Perth, Western Australia 6008, Australia.
Department of Anatomical Pathology, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar.
Surg Pathol Clin. 2016 Jun;9(2):227-41. doi: 10.1016/j.path.2016.01.002. Epub 2016 Apr 9.
Patients with germline DICER1 mutations are at increased risk of developing a wide range of tumors, most of which are relatively rare in the general population. In the gynecologic tract, these include ovarian sex cord-stromal tumors, particularly Sertoli-Leydig cell tumor, and embryonal rhabdomyosarcoma of the cervix. In some cases, these are the sentinel neoplasms. DICER1-associated tumors may have distinctive morphologic appearances that may prompt the pathologist to consider an underlying tumor predisposition syndrome and therefore consideration of genetic evaluation in the patient and her family.
携带种系DICER1突变的患者发生多种肿瘤的风险增加,其中大多数在普通人群中相对罕见。在女性生殖道中,这些肿瘤包括卵巢性索间质肿瘤,尤其是支持-莱迪希细胞瘤,以及宫颈胚胎性横纹肌肉瘤。在某些情况下,这些是前哨肿瘤。DICER1相关肿瘤可能具有独特的形态学表现,这可能促使病理学家考虑潜在的肿瘤易感综合征,从而考虑对患者及其家族进行基因评估。